With the benefit of hindsight, most recognize that the historic reliance on equities was too much of a concentrated bet.

It's not going to exercise that power for now, but it has expressly reserved this momentous power for the future.

Now, we're out there dealing with bedbugs every day of the week, all day long.

No drug or device has been regulated like this, ... It begs the question: Who gets to decide, Congress or FDA?

The issue I expect to dominate the debate is whether these deficits will unwind in an orderly way or in a disorderly way.

The FDA is asserting power to ban this industry.

The current account deficit is entirely sustainable and a natural consequence of globalization. In terms of fundamentals, there are no reasons why the dollar shouldn't be doing well.

I would submit the FDA jurisdiction is lawless, however honorable its intentions.

The debt equity swap carried by the Chinese is beginning to be rather costly, it is this organic realization rather than pushy comments from (U.S. Treasury Secretary) John Snow that is likely to trigger a change.